Procalcitonin to Shorten Antibiotics Duration in ICU Patients

NCT01379547 · Status: UNKNOWN · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 1700

Last updated 2012-11-27

No results posted yet for this study

Summary

The trial is aimed to show that implementation of a procalcitonin-guided antibiotics algorithm may result in shortened antibiotics course in ICU sepsis patients without inferior outcome as compared to the conventional therapy

Conditions

Interventions

BEHAVIORAL

Procalcitonin guided antibiotics treatment algorithm

Patients who will be randomized to arm 2 will receive antibiotics therapy with a duration based on procalcitonin measurement on day 5, 7 and 9.

BEHAVIORAL

Conventional treatment

Patients who will be randomized to arm 1 will receive antibiotic therapy with a duration based on conventional practice.

Sponsors & Collaborators

  • Beijing Chao Yang Hospital

    collaborator OTHER
  • Ruijin Hospital

    collaborator OTHER
  • Shanghai Jiao Tong University School of Medicine

    collaborator OTHER
  • Chongqing Medical University

    collaborator OTHER
  • Tianjin Medical University General Hospital

    collaborator OTHER
  • Chinese PLA General Hospital

    collaborator OTHER
  • Xinjiang Medical University

    collaborator OTHER
  • Princess Margaret Hospital, Hong Kong

    collaborator OTHER_GOV
  • National Taiwan University Hospital

    lead OTHER

Principal Investigators

  • Chien-Chang Lee, MD, MSc · National Taiwan University Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
20 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-06-30
Primary Completion
2012-12-31
Completion
2013-06-30

Countries

  • China
  • Hong Kong
  • Taiwan

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01379547 on ClinicalTrials.gov